Literature DB >> 27618778

Therapeutic lymphangiogenesis after myocardial infarction: vascular endothelial growth factor-C paves the way.

Polina Goichberg1.   

Abstract

Entities:  

Year:  2016        PMID： 27618778      PMCID： PMC4999773          DOI： 10.21037/jtd.2016.07.34

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  22 in total

1.  CARDIAC LYMPH FLOW IMPAIRMENT AND MYOCARDIAL FIBROSIS. EFFECTS OF CHRONIC OBSTRUCTION IN DOGS.

Authors:  I K KLINE; A J MILLER; L N KATZ
Journal:  Arch Pathol       Date:  1963-10

Review 2.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 3.  Biological basis of therapeutic lymphangiogenesis.

Authors:  Camilla Norrmén; Tuomas Tammela; Tatiana V Petrova; Kari Alitalo
Journal:  Circulation       Date:  2011-03-29       Impact factor: 29.690

4.  Morphometric analysis of the lymph system in rat heart during myocardial infarction.

Authors:  V V Stolyarov; E L Lushnikova; V P Zuevskii; A F Usynin
Journal:  Bull Exp Biol Med       Date:  2002-08       Impact factor: 0.804

5.  Endothelial progenitor cell transplantation decreases lymphangiogenesis and adverse myocardial remodeling in a mouse model of acute myocardial infarction.

Authors:  Jae-Hyeong Park; Jung Yeon Yoon; Seon Mi Ko; Seon Ah Jin; Jun Hyung Kim; Chung-Hyun Cho; Jin-Man Kim; Jae-Hwan Lee; Si Wan Choi; In-Whan Seong; Jin Ok Jeong
Journal:  Exp Mol Med       Date:  2011-08-31       Impact factor: 8.718

6.  A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities.

Authors:  V Joukov; V Kumar; T Sorsa; E Arighi; H Weich; O Saksela; K Alitalo
Journal:  J Biol Chem       Date:  1998-03-20       Impact factor: 5.157

7.  VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study.

Authors:  Mikko T Visuri; Krista M Honkonen; Pauliina Hartiala; Tomi V Tervala; Paavo J Halonen; Heikki Junkkari; Nina Knuutinen; Seppo Ylä-Herttuala; Kari K Alitalo; Anne M Saarikko
Journal:  Angiogenesis       Date:  2015-05-28       Impact factor: 9.596

8.  Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction.

Authors:  Orianne Henri; Chris Pouehe; Mahmoud Houssari; Ludovic Galas; Lionel Nicol; Florence Edwards-Lévy; Jean-Paul Henry; Anais Dumesnil; Inès Boukhalfa; Sébastien Banquet; Damien Schapman; Christian Thuillez; Vincent Richard; Paul Mulder; Ebba Brakenhielm
Journal:  Circulation       Date:  2016-03-01       Impact factor: 29.690

9.  Lymphangiogenesis in myocardial remodelling after infarction.

Authors:  Y Ishikawa; Y Akishima-Fukasawa; K Ito; Y Akasaka; M Tanaka; R Shimokawa; M Kimura-Matsumoto; H Morita; S Sato; I Kamata; T Ishii
Journal:  Histopathology       Date:  2007-09       Impact factor: 5.087

10.  Cardiac lymphatics are heterogeneous in origin and respond to injury.

Authors:  Linda Klotz; Sophie Norman; Joaquim Miguel Vieira; Megan Masters; Mala Rohling; Karina N Dubé; Sveva Bollini; Fumio Matsuzaki; Carolyn A Carr; Paul R Riley
Journal:  Nature       Date:  2015-06-04       Impact factor: 49.962
View more
  4 in total

1.  Phenotypically heterogeneous podoplanin-expressing cell populations are associated with the lymphatic vessel growth and fibrogenic responses in the acutely and chronically infarcted myocardium.

Authors:  Maria Cimini; Antonio Cannatá; Gianandrea Pasquinelli; Marcello Rota; Polina Goichberg
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

2.  Semaphorin3E-PlexinD1 signaling in coronary artery and lymphatic vessel development with clinical implications in myocardial recovery.

Authors:  Kazuaki Maruyama; Kazuaki Naemura; Yuichiro Arima; Yasunobu Uchijima; Hiroaki Nagao; Kenji Yoshihara; Manvendra K Singh; Akiyoshi Uemura; Fumio Matsuzaki; Yutaka Yoshida; Yukiko Kurihara; Sachiko Miyagawa-Tomita; Hiroki Kurihara
Journal:  iScience       Date:  2021-03-15

3.  Macrophage efferocytosis with VEGFC and lymphangiogenesis: rescuing the broken heart.

Authors:  Patricia A D'Amore; Pilar Alcaide
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

Review 4.  Future Needs in Mast Cell Biology.

Authors:  Gilda Varricchi; Amato de Paulis; Gianni Marone; Stephen J Galli
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.